These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 13634324)

  • 1. [Antifibromatous action of 17-alpha-progesterone acetate and 17-alpha-oxyprogesterone capronate].
    ROSSI PG
    Quad Clin Ostet Ginecol; 1959 Jan; 14(1):72-8. PubMed ID: 13634324
    [No Abstract]   [Full Text] [Related]  

  • 2. On the induction of molt in birds by 17 alpha-oxyprogesterone-17-capronate.
    KOBAYASHI H
    Endocrinology; 1958 Oct; 63(4):420-30. PubMed ID: 13586191
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with 17-alpha-oxyprogesterone-17-capronate].
    BOSCHANN HW
    Geburtshilfe Frauenheilkd; 1955 Dec; 15(12):1070-81. PubMed ID: 13294422
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental contribution to the action of 17 alpha-hydroxyprogesterone capronate, testosterone and desoxycorticosterone enanthate on the genital organs of impuberal rats].
    PEZZALI M; D'ALESSANDRO P
    Ann Ostet Ginecol; 1960 Jun; 82():698-700. PubMed ID: 13735107
    [No Abstract]   [Full Text] [Related]  

  • 5. [SYNTHESIS OF 17-ALPHA-OXYPROGESTERONE CAPRONATE].
    VEITSMAN AM; MOLEVA NI
    Farm Zh; 1965; 20():10-3. PubMed ID: 14348005
    [No Abstract]   [Full Text] [Related]  

  • 6. [Substitution of corpus luteum effect by 17-alpha-oxy-progesterone-capronate].
    RAUSCHER H
    Zentralbl Gynakol; 1958 Feb; 80(8):312-7. PubMed ID: 13558645
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of functional bleeding with 17 alpha-hydroxyprogesterone capronate; indication and limitations of treatment].
    ZORN H
    Geburtshilfe Frauenheilkd; 1958 Jul; 18(7):924-33. PubMed ID: 13574404
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of a new long-acting progestational compound (17-alpha-hydroxyprogesterone-capronate) in infertility and habitual abortion.
    TYLER ET
    Proc Soc Study Fertil; 1956; 8():85-99. PubMed ID: 13467587
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the diuretic effect of 6 alpha-methyl-17 alpha-hydroxyprogesterone acetate (MAP). Possibilities of a competitive action of aldosterone].
    D'ALESSANDRO B; BRANCACCIO A; JACONO G
    Boll Soc Ital Biol Sper; 1961 Aug; 37():724-7. PubMed ID: 13719126
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical & experimental research on a new progestational drug; 6 alpha-methyl-17 alpha-hydroxyprogesterone acetate].
    GOISIS M; CAVALLI P
    Minerva Ginecol; 1959 May; 11(10):431-40. PubMed ID: 13674178
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of progesterone, 17 alpha-hydroxyprogesterone acetate & hydroxyprogesterone caproate on the changes of uterine dynamics after deplorization of the membrane & subtraction of calcium: experimental data].
    ROSSI PG
    Quad Clin Ostet Ginecol; 1959 Feb; 14(2):79-97. PubMed ID: 13645888
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental clinical trials of a new progestational hormone: 6 alpha-methyl-17 alpha-hydroxyprogesterone acetate].
    GOISIS M; CAVALLI P
    Presse Med (1893); 1959 Jun; 67(32):1311-2. PubMed ID: 13675079
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental research on modifications of the blood sugar level induced by 6 alpha-methyl-17 alpha-hydroxyprogesterone acetate].
    RAGUCCI N
    Minerva Ginecol; 1960 Oct; 12():986-90. PubMed ID: 13739136
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative tests on the biological activity of 6 alpha-methyl-17 alpha-hydroxyprogesterone acetate and 17 alpha-hydroxyprogesterone acetate].
    MATSCHER R; LUPO C
    Boll Soc Ital Biol Sper; 1959 Jan; 35(1):18-20. PubMed ID: 13618435
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical & experimental research on a new progestational compound: 6 alpha-methyl-17 alpha-hydroxyprogesterone acetate (farlutal)].
    GOISIS M; CAVALLI P
    Riv Ostet Ginecol Prat; 1959 May; 41(5):474-90. PubMed ID: 13675725
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of 6 alpha-methyl-17 alpha-hydroxyprogesterone acetate on uterine motility in rats in comparison with 17 alpha-hydroxyprogesterone acetate].
    MATSCHER R; LUPO C
    Boll Soc Ital Biol Sper; 1959 Jan; 35(1):20-2. PubMed ID: 13618436
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synthesis of 19-nor-17 alpha-hydroxy-progesterone-capronate (gestanorone capronate)].
    Popper A; Prezewowsky K; Wiechert R; Gibian H; Raspé G
    Arzneimittelforschung; 1969 Mar; 19(3):352-4. PubMed ID: 5819384
    [No Abstract]   [Full Text] [Related]  

  • 18. [6-Methyl-6-dehydro-17 alpha-hydroxyprogester-one acetate and uterine dynamics. (Experimental study)].
    PAGANI C
    Ann Ostet Ginecol; 1961 Apr; 83():387-92. PubMed ID: 13732006
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interaction between 6-alpha-methyl-hydroxyprogesterone acetate and progesterone in McPhail's test].
    HECHT-LUCARI G; SALVATI A
    Ann Ostet Ginecol; 1960 Jun; 82():671-4. PubMed ID: 13712663
    [No Abstract]   [Full Text] [Related]  

  • 20. Biologic activity of 6-alph-amethyl compounds corresponding to progesterone, 17-alpha-hydroxyprogesterone acetate and compound S.
    GLENN EM; RICHARDSON SL; BOWMAN BJ
    Metabolism; 1959 May; 8(3):265-85. PubMed ID: 13656496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.